News Focus
News Focus
icon url

To infinity and beyond!

12/18/15 8:30 PM

#134238 RE: ImmunoATX #134221

p21 data already spoken of in many PR's

yes will be helpful if they have anything new- but that will already be out in PR's to come before a paper- doubt strongly they would hold back positive news given current sorry share price

they have already stood up at ASCO and presented data about Kevetrin on a couple of occasions for their peers

Strongly doubt pahse 1 data will go in a high impact journal- UNLESS there is new compelling data

No high impact journal that would publish what we have been told so far- hey everybody, a drug acting on p53 has proven to be safe

The methods and materials have been out for many moons already